CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 162 filers reported holding CLOVIS ONCOLOGY INC in Q4 2019. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,006,000 | -73.6% | 256,000 | 0.0% | 0.04% | -71.0% |
| Q2 2019 | $3,807,000 | -40.1% | 256,000 | 0.0% | 0.14% | -43.7% |
| Q1 2019 | $6,354,000 | +38.2% | 256,000 | 0.0% | 0.24% | +12.9% |
| Q4 2018 | $4,598,000 | -42.3% | 256,000 | -5.6% | 0.22% | -24.7% |
| Q3 2018 | $7,962,000 | -31.3% | 271,100 | +6.3% | 0.29% | -35.4% |
| Q2 2018 | $11,595,000 | -5.1% | 255,000 | +10.2% | 0.45% | -14.4% |
| Q1 2018 | $12,223,000 | -22.4% | 231,500 | 0.0% | 0.52% | -27.0% |
| Q4 2017 | $15,742,000 | -17.5% | 231,500 | 0.0% | 0.71% | -18.9% |
| Q3 2017 | $19,076,000 | -12.0% | 231,500 | 0.0% | 0.88% | -19.6% |
| Q2 2017 | $21,675,000 | +84.5% | 231,500 | +25.5% | 1.10% | +61.5% |
| Q1 2017 | $11,747,000 | +140.4% | 184,500 | +67.7% | 0.68% | +107.3% |
| Q4 2016 | $4,886,000 | +8.4% | 110,000 | -12.0% | 0.33% | +16.0% |
| Q3 2016 | $4,506,000 | +162.7% | 125,000 | 0.0% | 0.28% | +122.0% |
| Q2 2016 | $1,715,000 | -28.5% | 125,000 | 0.0% | 0.13% | -36.8% |
| Q1 2016 | $2,400,000 | -45.1% | 125,000 | 0.0% | 0.20% | -39.5% |
| Q4 2015 | $4,375,000 | – | 125,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |